arXiv subjects

Guantong Qi

Publications and source records attributed to Guantong Qi.

3 recordsLinked to original sources

arXiv2026

RareCollab: an LLM-powered framework for multimodal reasoning in Mendelian disease diagnosis

Rare disease diagnosis increasingly relies on integrating genomic, phenotypic and transcriptomic evidence, yet these signals remain difficult to reconcile within a common interpretive framework. Here we present RareCollab, an LLM-powered framework for multimodal reasoning in Mendelian disease diagnosis that integrates more than 100 diagnostic evidence signals across DNA, RNA, phenotype, curated variant-level knowledge, and in-silico pathogenicity evidence. This design enables large language models to operate as calibrated, interpretable reasoning modules rather than as a single end-to-end ranker. We applied RareCollab to 890 patients from three cohorts, including 119 Undiagnosed Diseases Network probands with paired DNA and RNA data, constituting a large systematic benchmark for multimodal rare disease diagnosis under paired genomic and transcriptomic evaluation. In this real-world multimodal benchmark, RareCollab prioritized 94% of diagnostic genes within the top 10. Across recall thresholds from top 1 to top 10, it consistently outperformed proprietary phenotype-driven LLM baselines including Claude Sonnet 4.6 and GPT-5-mini by more than 25% on average and surpassed established state-of-the-art variant prioritization methods by 11%-24%. RareCollab also reshapes the diagnostic contribution of RNA evidence, which contributes to prioritization of the diagnostic gene in 35% of cases (42/119). Together, these results establish RareCollab as a scalable and interpretable framework for multimodal rare disease diagnosis.

q-bio.GN↗

arXiv2025

ConSol: Sequential Probability Ratio Testing to Find Consistent LLM Reasoning Paths Efficiently

Recent advancements in large language models (LLMs) integrating explicit reasoning, such as OpenAI's o3-mini, DeepSeek-R1, and QWQ-32B, enable smaller models to solve complex tasks by generating intermediate reasoning steps prior to providing answers. However, this approach significantly increases computational costs, both monetarily and environmentally. The widely-used self-consistency method further exacerbates these costs by aggregating multiple reasoning paths to improve accuracy, often requiring between 40 to 64 samples per task. Although aggregation effectively reduces variance and bias, additional sampling can lead to diminishing returns when early samples yield consistent results. To address inefficiencies, we propose leveraging Sequential Probability Ratio Testing (SPRT) to dynamically terminate sampling once sufficient consistency is achieved. We calibrate SPRT parameters specifically for LLM applications, accounting for sensitivity to detect the mode of the distribution. Our experiments demonstrate that incorporating SPRT significantly enhances token efficiency, achieving comparable accuracy to self-consistency methods but at a substantially reduced computational cost. To promote transparency and facilitate reproducibility, we have made the source code and datasets used in our experiments publicly available at our GitHub repository: https://github.com/LiuzLab/consol, or available as a PyPI package: pip install consol. We hope that this resource will support further research and encourage the development of new methods building upon our work.

cs.LG↗

arXiv2025

Survey and Improvement Strategies for Gene Prioritization with Large Language Models

Rare diseases are challenging to diagnose due to limited patient data and genetic diversity. Despite advances in variant prioritization, many cases remain undiagnosed. While large language models (LLMs) have performed well in medical exams, their effectiveness in diagnosing rare genetic diseases has not been assessed. To identify causal genes, we benchmarked various LLMs for gene prioritization. Using multi-agent and Human Phenotype Ontology (HPO) classification, we categorized patients based on phenotypes and solvability levels. As gene set size increased, LLM performance deteriorated, so we used a divide-and-conquer strategy to break the task into smaller subsets. At baseline, GPT-4 outperformed other LLMs, achieving near 30% accuracy in ranking causal genes correctly. The multi-agent and HPO approaches helped distinguish confidently solved cases from challenging ones, highlighting the importance of known gene-phenotype associations and phenotype specificity. We found that cases with specific phenotypes or clear associations were more accurately solved. However, we observed biases toward well-studied genes and input order sensitivity, which hindered gene prioritization. Our divide-and-conquer strategy improved accuracy by overcoming these biases. By utilizing HPO classification, novel multi-agent techniques, and our LLM strategy, we improved causal gene identification accuracy compared to our baseline evaluation. This approach streamlines rare disease diagnosis, facilitates reanalysis of unsolved cases, and accelerates gene discovery, supporting the development of targeted diagnostics and therapies.

q-bio.GN↗